<?xml version="1.0" encoding="UTF-8"?><measure><measureDetails><uuid>40280381-3e93-d1af-013e-a49f8f204114</uuid><title>HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis</title><shortTitle>HIV AIDS Pneumocystis jiroveci</shortTitle><emeasureid>52</emeasureid><guid>1cdd20de-5de9-4759-8a93-31f1f8baaaa2</guid><version>3</version><status>In Progress</status><nqfid extension="0405" root="2.16.840.1.113883.3.560.1"/><period uuid="40280381-3e93-d1af-013e-a49f8f3f4136"><startDate uuid="4a3e9ec7-cf56-4636-9c1e-7ce6211b6986">00000101</startDate><stopDate uuid="235753a1-913e-4332-924a-a603a743f51d">00001231</stopDate></period><steward id="2.16.840.1.113883.3.464">National Committee for Quality Assurance</steward><developers><developer id="afb4c440-493c-4260-9238-a1cfa12f0537">National Committee for Quality Assurance/ and American Medical Association - convened Physician Consortium for Performance Improvement (AMA-PCPI)</developer></developers><endorsement id="2.16.840.1.113883.3.560">National Quality Forum</endorsement><description>Percentage of patients aged 6 weeks and older with a diagnosis of HIV/AIDS who were prescribed Pneumocystis jiroveci pneumonia (PCP) prophylaxis</description><copyright>Copyright 2013 National Committee for Quality Assurance (NCQA) and American Medical Association. All Rights Reserved.</copyright><disclaimer>Physician Performance Measures (Measures) and related data specifications have been developed by the American Medical Association (AMA) - convened Physician Consortium for Performance Improvement(R) (PCPI[R]) and the National Committee for Quality Assurance (NCQA). These Measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications. The Measures, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, e.g., use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial uses of the Measures require a license agreement between the user and the AMA, (on behalf of the PCPI) or NCQA. Neither the AMA, PCPI, NCQA nor its members shall be responsible for any use of the Measures.&#xD;
&#xD;
THE MEASURES AND SPECIFICATIONS ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND.&#xD;
&#xD;
Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The AMA, PCPI, NCQA and its members disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT[R]) or other coding contained in the specifications.&#xD;
&#xD;
CPT(R) contained in the Measure specifications is copyright 2004-2013 American Medical Association. LOINC(R) copyright 2004-2013 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2013 International Health Terminology Standards Development Organisation. ICD-10 copyright 2013 World Health Organization. All Rights Reserved.&#xD;
&#xD;
Due to technical limitations, registered trademarks are indicated by (R) or [R] and unregistered trademarks are indicated by (TM) or [TM].</disclaimer><scoring id="PROPOR">Proportion</scoring><types><type id="PROCESS">Process</type></types><stratification>None</stratification><riskAdjustment>None</riskAdjustment><aggregation>None</aggregation><rationale>Although advances in the management of HIV and AIDS diseases have been made, Pneumocystis carinii pneumonia (PCP) remains an important complication and cause of morbidity.  Without PCP prophylaxis, patients with HIV/AIDS are at increased risk of developing PCP, especially when CD4 cell counts fall 200mm3-250mm3 (Kaplan, 1998; Phair, 1990).  PCP prophylaxis is very effective and has been demonstrated to prolong life.   &#xD;
&#xD;
Data from Kaiser Permanente suggests that a gap exists between what is recommended for patients with HIV infection, and what is actually performed.  According to 2005-2006 data from Kaiser Permanente California (both Northern and Southern), Georgia, and Oregon, only 71% of HIV-infected persons with a CD4&lt;200mm3 received PCP prophylaxis (personal communication, 2007).</rationale><recommendations>HIV-infected adults and adolescents, including pregnant women and those on HAART, should receive chemoprophylaxis against PCP if they have a CD4+T lymphocyte count of &lt;200/mL or a history of oropharyngeal candidiasis. (USPH/IDSA, 2002)</recommendations><improvementNotations>A higher score indicates better quality</improvementNotations><references><reference>Kaplan JE, Hanson DL, Navin TR, Jones JL. Risk factors for primary Pneumocystis carinii pneumonia in human immunodeficiency virus--infected adolescents and adults in the United States: reassessment of indications for chemoprophylaxis. The Journal of Infectious Diseases. 1998;178:1126-32. </reference><reference>Personal communication. Michael Horberg, MD, Director, HIV/AIDS Policy, Quality Improvement, Research, The Permanente Federation. 2007 Nov 6.  &#xD;
</reference><reference>Phair J, Munoz A, Detels R, Kaslow R, Rinaldo C, Saah A. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. NEJM. 1990 Jan 18;322:161-65.   </reference></references><definitions>None</definitions><guidance>Denominator 1: The CD4 count below 200 cells/mm3 must occur during the first nine months of the year.&#xD;
&#xD;
Denominator 2: The CD4 count below 500 cells/mm3 or the CD4 percentage below 15% must occur during the first nine months of the year.&#xD;
&#xD;
Once all denominators and numerators are calculated, a total rate should be calculated using the sum of the three denominators and the sum of the three numerators.</guidance><transmissionFormat>TBD</transmissionFormat><initialPatientPopDescription>Denominator 1: All patients aged 6 years and older with a diagnosis of HIV/AIDS and a CD4 count below 200 cells/mm3 who had at least two visits during the measurement year, with at least 90 days in between each visit&#xD;
&#xD;
Denominator 2: All patients aged 1-5 years of age with a diagnosis of HIV/AIDS and a CD4 count below 500 cells/mm3 or a CD4 percentage below 15% who had at least two visits during the measurement year, with at least 90 days in between each visit&#xD;
&#xD;
Denominator 3: All patients aged 6 weeks to 12 months with a diagnosis of HIV who had at least two visits during the measurement year, with at least 90 days in between each visit</initialPatientPopDescription><denominatorDescription>Equals Initial Patient Population</denominatorDescription><denominatorExclusionsDescription>None</denominatorExclusionsDescription><numeratorDescription>Numerator 1: Patients who were prescribed pneumocystis jiroveci pneumonia (PCP) prophylaxis within 3 months of CD4 count below 200 cells/mm3&#xD;
&#xD;
Numerator 2: Patients who were prescribed pneumocystis jiroveci pneumonia (PCP) prophylaxis within 3 months of CD4 count below 500 cells/ mm3 or a CD4 percentage below 15%&#xD;
&#xD;
Numerator 3: Patients who were prescribed Pneumocystis jiroveci pneumonia (PCP) prophylaxis at the time of diagnosis of HIV</numeratorDescription><numeratorExclusionsDescription>Not Applicable</numeratorExclusionsDescription><denominatorExceptionsDescription>Numerator 1: Patient did not receive PCP prophylaxis because there was a CD4 count above 200 cells/mm3 during the three months after a CD4 count below 200 cells/mm3 &#xD;
&#xD;
Numerator 2: Patient did not receive PCP prophylaxis because there was a CD4 count above 500 cells/mm3 or CD4 percentage above 15% during the three months after a CD4 count below 500 cells/mm3 or CD4 percentage below 15% &#xD;
&#xD;
Numerator 3: None</denominatorExceptionsDescription><measurePopulationDescription>Not Applicable</measurePopulationDescription><measureObservationsDescription>Not Applicable</measureObservationsDescription><supplementalData>For every patient evaluated by this measure also identify payer, race, ethnicity, and sex.</supplementalData><qualityMeasureSet uuid="9cbb2a0c-7014-48a7-9cf0-2f5b2ed46221">Not Applicable</qualityMeasureSet>
<finalizedDate value="201404221349-0500"/>
</measureDetails><supplementalDataElements><elementRef id="40280381-3e93-d1af-013e-a49f8f3d4115" name="ONC Administrative Sex"/><elementRef id="40280381-3e93-d1af-013e-a49f8f3d4116" name="Race"/><elementRef id="40280381-3e93-d1af-013e-a49f8f3d4117" name="Ethnicity"/><elementRef id="40280381-3e93-d1af-013e-a49f8f3d4118" name="Payer"/></supplementalDataElements><measureGrouping><group sequence="2"><clause displayName="Initial Patient Population 2" type="initialPatientPopulation" uuid="92AA465B-09B1-40CE-864F-77BD99028638"><logicalOp displayName="AND" type="and"><relationalOp displayName="&gt;= 1 years Starts Before Start Of" operatorType="Greater Than or Equal To" quantity="1" type="SBS" unit="years"><elementRef displayName="birth date : Patient Characteristic Birthdate" id="40280381-3e93-d1af-013e-a49f8f3f4140" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></relationalOp><relationalOp displayName="&lt; 6 years Starts Before Start Of" operatorType="Less Than" quantity="6" type="SBS" unit="years"><elementRef displayName="birth date : Patient Characteristic Birthdate" id="40280381-3e93-d1af-013e-a49f8f3f4140" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></relationalOp><relationalOp displayName="Starts Before Or During" type="SBOD"><elementRef displayName="HIV : Diagnosis, Active" id="40280381-3e93-d1af-013e-a49f8f3d411a" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></relationalOp><relationalOp displayName="During" type="DURING"><elementRef displayName="Occurrence A of HIV Visit : Encounter, Performed" id="40280381-3e93-d1af-013e-a49f8f3d411d" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></relationalOp><relationalOp displayName="During" type="DURING"><elementRef displayName="Occurrence B of HIV Visit : Encounter, Performed" id="40280381-3e93-d1af-013e-a49f8f3d411e" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></relationalOp><logicalOp displayName="OR" type="or"><relationalOp displayName="&lt; 9 months Ends After Start Of" operatorType="Less Than" quantity="9" type="EAS" unit="months"><elementRef displayName="Occurrence A of CD4+ Count : Laboratory Test, Result" id="40280381-3e93-d1af-013e-a49f8f3d411f" type="qdm"><attribute comparisonValue="500" mode="Less Than" name="result" unit="per mm3"/></elementRef><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></relationalOp><relationalOp displayName="&lt; 9 months Ends After Start Of" operatorType="Less Than" quantity="9" type="EAS" unit="months"><elementRef displayName="Occurrence A of CD4+ Percentage : Laboratory Test, Result" id="40280381-3e93-d1af-013e-a49f8f3e412a" type="qdm"><attribute comparisonValue="15" mode="Less Than" name="result" unit="%"/></elementRef><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></relationalOp></logicalOp><relationalOp displayName="&gt;= 90 days Starts After End Of" operatorType="Greater Than or Equal To" quantity="90" type="SAE" unit="days"><elementRef displayName="Occurrence B of HIV Visit : Encounter, Performed" id="40280381-3e93-d1af-013e-a49f8f3d411e" type="qdm"/><elementRef displayName="Occurrence A of HIV Visit : Encounter, Performed" id="40280381-3e93-d1af-013e-a49f8f3d411d" type="qdm"/></relationalOp></logicalOp></clause><clause displayName="Denominator 2" type="denominator" uuid="4C3F3589-4192-4944-A4BC-AA3B50A0900B"><logicalOp displayName="AND" type="and"/></clause><clause displayName="Denominator Exceptions 2" type="denominatorExceptions" uuid="E46E5FE8-4429-4AAE-88FC-F949CD0714B4"><logicalOp displayName="AND" type="and"><logicalOp displayName="OR" type="or"><relationalOp displayName="&lt;= 3 months Ends After End Of" operatorType="Less Than or Equal To" quantity="3" type="EAE" unit="months"><elementRef displayName="Occurrence B of CD4+ Count : Laboratory Test, Result" id="40280381-3e93-d1af-013e-a49f8f3d4120" type="qdm"><attribute comparisonValue="500" mode="Greater Than or Equal To" name="result" unit="per mm3"/></elementRef><elementRef displayName="Occurrence A of CD4+ Count : Laboratory Test, Result" id="40280381-3e93-d1af-013e-a49f8f3d411f" type="qdm"/></relationalOp><relationalOp displayName="&lt;= 3 months Ends After End Of" operatorType="Less Than or Equal To" quantity="3" type="EAE" unit="months"><elementRef displayName="Occurrence B of CD4+ Percentage : Laboratory Test, Result" id="40280381-3e93-d1af-013e-a49f8f3e4135" type="qdm"><attribute comparisonValue="15" mode="Greater Than or Equal To" name="result" unit="%"/></elementRef><elementRef displayName="Occurrence A of CD4+ Percentage : Laboratory Test, Result" id="40280381-3e93-d1af-013e-a49f8f3e412a" type="qdm"/></relationalOp></logicalOp></logicalOp></clause><clause displayName="Numerator 2" type="numerator" uuid="4FDA8306-EC79-4C49-ACB0-0E40E2C79592"><logicalOp displayName="AND" type="and"><logicalOp displayName="OR" type="or"><relationalOp displayName="&lt;= 3 months Starts After End Of" operatorType="Less Than or Equal To" quantity="3" type="SAE" unit="months"><elementRef displayName="Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3d4122" type="qdm"/><elementRef displayName="Occurrence A of CD4+ Count : Laboratory Test, Result" id="40280381-3e93-d1af-013e-a49f8f3d411f" type="qdm"/></relationalOp><relationalOp displayName="&lt;= 3 months Starts After End Of" operatorType="Less Than or Equal To" quantity="3" type="SAE" unit="months"><elementRef displayName="Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3d4122" type="qdm"/><elementRef displayName="Occurrence A of CD4+ Percentage : Laboratory Test, Result" id="40280381-3e93-d1af-013e-a49f8f3e412a" type="qdm"/></relationalOp></logicalOp></logicalOp></clause></group><group sequence="3"><clause displayName="Initial Patient Population 3" type="initialPatientPopulation" uuid="3D78BD99-8D9E-45EE-8B26-F55774293F1C"><logicalOp displayName="AND" type="and"><relationalOp displayName="&gt;= 6 weeks Starts Before Start Of" operatorType="Greater Than or Equal To" quantity="6" type="SBS" unit="weeks"><elementRef displayName="birth date : Patient Characteristic Birthdate" id="40280381-3e93-d1af-013e-a49f8f3f4140" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></relationalOp><relationalOp displayName="&lt; 1 years Starts Before Start Of" operatorType="Less Than" quantity="1" type="SBS" unit="years"><elementRef displayName="birth date : Patient Characteristic Birthdate" id="40280381-3e93-d1af-013e-a49f8f3f4140" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></relationalOp><functionalOp displayName="FIRST" type="FIRST" uuid="3476ed35-6c0c-40a5-b0b3-d8de438e156f"><relationalOp displayName="Starts Before Or During" type="SBOD"><elementRef displayName="Occurrence A of HIV : Diagnosis, Active" id="40280381-3e93-d1af-013e-a49f8f3f4138" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></relationalOp></functionalOp><relationalOp displayName="During" type="DURING"><elementRef displayName="Occurrence A of HIV Visit : Encounter, Performed" id="40280381-3e93-d1af-013e-a49f8f3d411d" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></relationalOp><relationalOp displayName="During" type="DURING"><elementRef displayName="Occurrence B of HIV Visit : Encounter, Performed" id="40280381-3e93-d1af-013e-a49f8f3d411e" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></relationalOp><relationalOp displayName="&gt;= 90 days Starts After End Of" operatorType="Greater Than or Equal To" quantity="90" type="SAE" unit="days"><elementRef displayName="Occurrence B of HIV Visit : Encounter, Performed" id="40280381-3e93-d1af-013e-a49f8f3d411e" type="qdm"/><elementRef displayName="Occurrence A of HIV Visit : Encounter, Performed" id="40280381-3e93-d1af-013e-a49f8f3d411d" type="qdm"/></relationalOp></logicalOp></clause><clause displayName="Denominator 3" type="denominator" uuid="5F7B8189-41D7-4BE7-869C-88F1BC63220F"><logicalOp displayName="AND" type="and"/></clause><clause displayName="Denominator Exceptions 3" type="denominatorExceptions" uuid="C7EFB63E-3A3F-47E9-8E0F-B2FB1344F4A4"><logicalOp displayName="AND" type="and"/></clause><clause displayName="Numerator 3" type="numerator" uuid="B7A915BC-EFC7-44D9-843C-928B40C4308C"><logicalOp displayName="AND" type="and"><logicalOp displayName="OR" type="or"><relationalOp displayName="&lt; 1 days Starts After Start Of" operatorType="Less Than" quantity="1" type="SAS" unit="days"><elementRef displayName="Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3d4122" type="qdm"/><elementRef displayName="Occurrence A of HIV : Diagnosis, Active" id="40280381-3e93-d1af-013e-a49f8f3f4138" type="qdm"/></relationalOp><relationalOp displayName="    Starts Concurrent With" quantity="" type="SCW"><elementRef displayName="Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3d4122" type="qdm"/><elementRef displayName="Occurrence A of HIV : Diagnosis, Active" id="40280381-3e93-d1af-013e-a49f8f3f4138" type="qdm"/></relationalOp></logicalOp></logicalOp></clause></group><group sequence="1"><clause displayName="Initial Patient Population 1" type="initialPatientPopulation" uuid="CEF51916-44BA-400D-B67F-FE21CB44523B"><logicalOp displayName="AND" type="and"><relationalOp displayName="&gt;= 6 years Starts Before Start Of" operatorType="Greater Than or Equal To" quantity="6" type="SBS" unit="years"><elementRef displayName="birth date : Patient Characteristic Birthdate" id="40280381-3e93-d1af-013e-a49f8f3f4140" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></relationalOp><relationalOp displayName="Starts Before Or During" type="SBOD"><elementRef displayName="HIV : Diagnosis, Active" id="40280381-3e93-d1af-013e-a49f8f3d411a" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></relationalOp><relationalOp displayName="During" type="DURING"><elementRef displayName="Occurrence A of HIV Visit : Encounter, Performed" id="40280381-3e93-d1af-013e-a49f8f3d411d" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></relationalOp><relationalOp displayName="During" type="DURING"><elementRef displayName="Occurrence B of HIV Visit : Encounter, Performed" id="40280381-3e93-d1af-013e-a49f8f3d411e" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></relationalOp><relationalOp displayName="&lt; 9 months Ends After Start Of" operatorType="Less Than" quantity="9" type="EAS" unit="months"><elementRef displayName="Occurrence A of CD4+ Count : Laboratory Test, Result" id="40280381-3e93-d1af-013e-a49f8f3d411f" type="qdm"><attribute comparisonValue="200" mode="Less Than" name="result" unit="per mm3"/></elementRef><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></relationalOp><relationalOp displayName="&gt;= 90 days Starts After End Of" operatorType="Greater Than or Equal To" quantity="90" type="SAE" unit="days"><elementRef displayName="Occurrence B of HIV Visit : Encounter, Performed" id="40280381-3e93-d1af-013e-a49f8f3d411e" type="qdm"/><elementRef displayName="Occurrence A of HIV Visit : Encounter, Performed" id="40280381-3e93-d1af-013e-a49f8f3d411d" type="qdm"/></relationalOp></logicalOp></clause><clause displayName="Denominator 1" type="denominator" uuid="A456B8FC-CCF3-40F2-84C2-7940D1AC383F"><logicalOp displayName="AND" type="and"/></clause><clause displayName="Denominator Exceptions 1" type="denominatorExceptions" uuid="D840A624-6BDD-4B6F-8521-A397C5607614"><logicalOp displayName="AND" type="and"><relationalOp displayName="&lt;= 3 months Ends After End Of" operatorType="Less Than or Equal To" quantity="3" type="EAE" unit="months"><elementRef displayName="Occurrence B of CD4+ Count : Laboratory Test, Result" id="40280381-3e93-d1af-013e-a49f8f3d4120" type="qdm"><attribute comparisonValue="200" mode="Greater Than or Equal To" name="result" unit="per mm3"/></elementRef><elementRef displayName="Occurrence A of CD4+ Count : Laboratory Test, Result" id="40280381-3e93-d1af-013e-a49f8f3d411f" type="qdm"/></relationalOp></logicalOp></clause><clause displayName="Numerator 1" type="numerator" uuid="61C7476F-EBDC-4844-9533-69992523DD39"><logicalOp displayName="AND" type="and"><logicalOp displayName="OR" type="or"><relationalOp displayName="&lt;= 3 months Starts After End Of" operatorType="Less Than or Equal To" quantity="3" type="SAE" unit="months"><elementRef displayName="Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3d4122" type="qdm"/><elementRef displayName="Occurrence A of CD4+ Count : Laboratory Test, Result" id="40280381-3e93-d1af-013e-a49f8f3d411f" type="qdm"/></relationalOp><logicalOp displayName="AND" type="and"><relationalOp displayName="&lt;= 3 months Starts After End Of" operatorType="Less Than or Equal To" quantity="3" type="SAE" unit="months"><elementRef displayName="Occurrence A of Dapsone and pyrimethamine : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3f413b" type="qdm"/><elementRef displayName="Occurrence A of CD4+ Count : Laboratory Test, Result" id="40280381-3e93-d1af-013e-a49f8f3d411f" type="qdm"/></relationalOp><relationalOp displayName="&lt;= 3 months Starts After End Of" operatorType="Less Than or Equal To" quantity="3" type="SAE" unit="months"><elementRef displayName="Occurrence A of Leucovorin : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3e4127" type="qdm"/><elementRef displayName="Occurrence A of CD4+ Count : Laboratory Test, Result" id="40280381-3e93-d1af-013e-a49f8f3d411f" type="qdm"/></relationalOp><logicalOp displayName="OR" type="or"><relationalOp displayName="Concurrent With" type="CONCURRENT"><elementRef displayName="Occurrence A of Leucovorin : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3e4127" type="qdm"/><elementRef displayName="Occurrence A of Dapsone and pyrimethamine : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3f413b" type="qdm"/></relationalOp><logicalOp displayName="AND" type="and"><relationalOp displayName="&lt; 1 days Starts Before Or During" operatorType="Less Than" quantity="1" type="SBOD" unit="days"><elementRef displayName="Occurrence A of Dapsone and pyrimethamine : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3f413b" type="qdm"/><elementRef displayName="Occurrence A of Leucovorin : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3e4127" type="qdm"/></relationalOp><functionalOp displayName="NOT" type="NOT" uuid="15b0297a-5c21-443e-8c87-dfaeff3bd95d"><relationalOp displayName="Ends Before Start Of" type="EBS"><elementRef displayName="Occurrence A of Dapsone and pyrimethamine : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3f413b" type="qdm"/><elementRef displayName="Occurrence A of Leucovorin : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3e4127" type="qdm"/></relationalOp></functionalOp></logicalOp><logicalOp displayName="AND" type="and"><relationalOp displayName="&lt; 1 days Starts Before Or During" operatorType="Less Than" quantity="1" type="SBOD" unit="days"><elementRef displayName="Occurrence A of Leucovorin : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3e4127" type="qdm"/><elementRef displayName="Occurrence A of Dapsone and pyrimethamine : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3f413b" type="qdm"/></relationalOp><functionalOp displayName="NOT" type="NOT" uuid="7ec2ec3a-8869-4da2-a5ff-5e0e5eb3e7e7"><relationalOp displayName="Ends Before Start Of" type="EBS"><elementRef displayName="Occurrence A of Leucovorin : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3e4127" type="qdm"/><elementRef displayName="Occurrence A of Dapsone and pyrimethamine : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3f413b" type="qdm"/></relationalOp></functionalOp></logicalOp></logicalOp></logicalOp></logicalOp></logicalOp></clause></group></measureGrouping><elementLookUp><qdm codeSystemName="National Quality Forum" datatype="Patient Characteristic Birthdate" id="40280381-3e93-d1af-013e-a49f8f3f4140" name="birth date" oid="2.16.840.1.113883.3.560.100.4" suppDataElement="false" taxonomy="LOINC" uuid="40280381-3e93-d1af-013e-a49f8f3f4140" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Laboratory Test, Result" id="40280381-3e93-d1af-013e-a49f8f3d411f" instance="Occurrence A" name="CD4+ Count" oid="2.16.840.1.113883.3.464.1003.121.12.1004" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013e-a49f8f3d411f" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Laboratory Test, Result" id="40280381-3e93-d1af-013e-a49f8f3d4120" instance="Occurrence B" name="CD4+ Count" oid="2.16.840.1.113883.3.464.1003.121.12.1004" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013e-a49f8f3d4120" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Laboratory Test, Result" id="40280381-3e93-d1af-013e-a49f8f3e412a" instance="Occurrence A" name="CD4+ Percentage" oid="2.16.840.1.113883.3.464.1003.121.12.1005" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013e-a49f8f3e412a" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Laboratory Test, Result" id="40280381-3e93-d1af-013e-a49f8f3e4135" instance="Occurrence B" name="CD4+ Percentage" oid="2.16.840.1.113883.3.464.1003.121.12.1005" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013e-a49f8f3e4135" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3f413b" instance="Occurrence A" name="Dapsone and pyrimethamine" oid="2.16.840.1.113883.3.464.1003.196.12.1202" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013e-a49f8f3f413b" version="1"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Ethnicity" id="40280381-3e93-d1af-013e-a49f8f3d4117" name="Ethnicity" oid="2.16.840.1.114222.4.11.837" suppDataElement="true" taxonomy="CDCREC" uuid="40280381-3e93-d1af-013e-a49f8f3d4117" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Diagnosis, Active" id="40280381-3e93-d1af-013e-a49f8f3f4138" instance="Occurrence A" name="HIV" oid="2.16.840.1.113883.3.464.1003.120.12.1003" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013e-a49f8f3f4138" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3e93-d1af-013e-a49f8f3d411d" instance="Occurrence A" name="HIV Visit" oid="2.16.840.1.113883.3.464.1003.101.12.1047" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013e-a49f8f3d411d" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3e93-d1af-013e-a49f8f3d411e" instance="Occurrence B" name="HIV Visit" oid="2.16.840.1.113883.3.464.1003.101.12.1047" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013e-a49f8f3d411e" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3e4127" instance="Occurrence A" name="Leucovorin" oid="2.16.840.1.113883.3.464.1003.196.12.1205" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013e-a49f8f3e4127" version="1"/><qdm codeSystemName="National Quality Forum" datatype="Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" name="Measurement Period" oid="2.16.840.1.113883.3.67.1.101.1.53" suppDataElement="false" taxonomy="NQF" uuid="40280381-3e93-d1af-013e-a49f8f3f4136" version="1"/><qdm codeSystemName="National Library of Medicine" datatype="Patient Characteristic Sex" id="40280381-3e93-d1af-013e-a49f8f3d4115" name="ONC Administrative Sex" oid="2.16.840.1.113762.1.4.1" suppDataElement="true" taxonomy="AdministrativeSex" uuid="40280381-3e93-d1af-013e-a49f8f3d4115" version="1"/><qdm codeSystemName="PHDSC" datatype="Patient Characteristic Payer" id="40280381-3e93-d1af-013e-a49f8f3d4118" name="Payer" oid="2.16.840.1.114222.4.11.3591" suppDataElement="true" taxonomy="SOP" uuid="40280381-3e93-d1af-013e-a49f8f3d4118" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3d4122" name="Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis" oid="2.16.840.1.113883.3.464.1003.196.12.1076" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013e-a49f8f3d4122" version="1"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Race" id="40280381-3e93-d1af-013e-a49f8f3d4116" name="Race" oid="2.16.840.1.114222.4.11.836" suppDataElement="true" taxonomy="CDCREC" uuid="40280381-3e93-d1af-013e-a49f8f3d4116" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Laboratory Test, Result" id="5e924ab7-99b6-4b5a-a6ae-6f3a872e21cc" name="CD4+ Count" oid="2.16.840.1.113883.3.464.1003.121.12.1004" suppDataElement="false" taxonomy="Grouping" uuid="5e924ab7-99b6-4b5a-a6ae-6f3a872e21cc" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Laboratory Test, Result" id="df8d02ca-b97a-4bd7-8025-54532d45d034" name="CD4+ Percentage" oid="2.16.840.1.113883.3.464.1003.121.12.1005" suppDataElement="false" taxonomy="Grouping" uuid="df8d02ca-b97a-4bd7-8025-54532d45d034" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Medication, Order" id="f9d963ed-e987-4acd-b5dc-0afa2d3f306b" name="Dapsone and pyrimethamine" oid="2.16.840.1.113883.3.464.1003.196.12.1202" suppDataElement="false" taxonomy="Grouping" uuid="f9d963ed-e987-4acd-b5dc-0afa2d3f306b" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Diagnosis, Active" id="40280381-3e93-d1af-013e-a49f8f3d411a" name="HIV" oid="2.16.840.1.113883.3.464.1003.120.12.1003" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013e-a49f8f3d411a" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="1df2cef4-5b73-4794-9119-f05070b29365" name="HIV Visit" oid="2.16.840.1.113883.3.464.1003.101.12.1047" suppDataElement="false" taxonomy="Grouping" uuid="1df2cef4-5b73-4794-9119-f05070b29365" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Medication, Order" id="60ae4f89-634c-4190-8db2-051126d5f972" name="Leucovorin" oid="2.16.840.1.113883.3.464.1003.196.12.1205" suppDataElement="false" taxonomy="Grouping" uuid="60ae4f89-634c-4190-8db2-051126d5f972" version="1"/></elementLookUp><strata displayName="Stratification"><clause displayName="Stratum 1" type="stratum" uuid="40280381-3e93-d1af-013e-a49fef9041f5"><logicalOp displayName="AND" type="and"/></clause></strata></measure>
